United States Musculoskeletal Disorders Therapeutics Market Report 2017

United States Musculoskeletal Disorders Therapeutics Market Report 2017

1 Musculoskeletal Disorders Therapeutics Overview

1.1 Product Overview and Scope of Musculoskeletal Disorders Therapeutics

1.2 Classification of Musculoskeletal Disorders Therapeutics

1.2.1 Biologics

1.2.2 Small Molecules

1.3 Application of Musculoskeletal Disorders Therapeutics

1.3.1 Osteoarthritis

1.3.2 Osteoporosis

1.3.3 Psoriatic Arthritis

1.3.4 Ankylosing Spondylitis

1.3.5 Fibromyalgia

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Musculoskeletal Disorders Therapeutics (2012-2022)

1.4.1 United States Musculoskeletal Disorders Therapeutics Sales and Growth Rate (2012-2022)

1.4.2 United States Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Musculoskeletal Disorders Therapeutics Competition by Manufacturers

2.1 United States Musculoskeletal Disorders Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Musculoskeletal Disorders Therapeutics Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Musculoskeletal Disorders Therapeutics Average Price by Manufactures (2015 and 2016)

2.4 Musculoskeletal Disorders Therapeutics Market Competitive Situation and Trends

2.4.1 Musculoskeletal Disorders Therapeutics Market Concentration Rate

2.4.2 Musculoskeletal Disorders Therapeutics Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Musculoskeletal Disorders Therapeutics Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Musculoskeletal Disorders Therapeutics Sales and Market Share by States (2012-2017)

3.2 United States Musculoskeletal Disorders Therapeutics Revenue and Market Share by States (2012-2017)

3.3 United States Musculoskeletal Disorders Therapeutics Price by States (2012-2017)

4 United States Musculoskeletal Disorders Therapeutics Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Musculoskeletal Disorders Therapeutics Sales and Market Share by Type (2012-2017)

4.2 United States Musculoskeletal Disorders Therapeutics Revenue and Market Share by Type (2012-2017)

4.3 United States Musculoskeletal Disorders Therapeutics Price by Type (2012-2017)

4.4 United States Musculoskeletal Disorders Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Musculoskeletal Disorders Therapeutics Sales (Volume) by Application (2012-2017)

5.1 United States Musculoskeletal Disorders Therapeutics Sales and Market Share by Application (2012-2017)

5.2 United States Musculoskeletal Disorders Therapeutics Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Musculoskeletal Disorders Therapeutics Manufacturers Profiles/Analysis

6.1 AbbVie

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 AbbVie Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Johnson & Johnson

6.2.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Amgen

6.3.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Amgen Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Pfizer

6.4.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Pfizer Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 F. Hoffmann-La Roche

6.5.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Eli Lilly

6.6.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Merck

6.7.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Merck Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Novartis

6.8.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Novartis Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 AstraZeneca

6.9.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Astellas

6.10.2 Musculoskeletal Disorders Therapeutics Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Astellas Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 AB Sciences

6.12 3SBio

6.13 Samsung Bioepis

6.14 Sanofi

6.15 Taisho Pharmaceutical

6.16 Takeda

6.17 Zosano Pharma

6.18 LG Life Sciences

7 Musculoskeletal Disorders Therapeutics Manufacturing Cost Analysis

7.1 Musculoskeletal Disorders Therapeutics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Musculoskeletal Disorders Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Musculoskeletal Disorders Therapeutics Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Musculoskeletal Disorders Therapeutics Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Musculoskeletal Disorders Therapeutics Market Forecast (2017-2022)

11.1 United States Musculoskeletal Disorders Therapeutics Sales, Revenue Forecast (2017-2022)

11.2 United States Musculoskeletal Disorders Therapeutics Sales Forecast by Type (2017-2022)

11.3 United States Musculoskeletal Disorders Therapeutics Sales Forecast by Application (2017-2022)

11.4 Musculoskeletal Disorders Therapeutics Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Musculoskeletal Disorders Therapeutics

Table Classification of Musculoskeletal Disorders Therapeutics

Figure United States Sales Market Share of Musculoskeletal Disorders Therapeutics by Type in 2015

Figure Biologics Picture

Figure Small Molecules Picture

Table Application of Musculoskeletal Disorders Therapeutics

Figure United States Sales Market Share of Musculoskeletal Disorders Therapeutics by Application in 2015

Figure Osteoarthritis Examples

Figure Osteoporosis Examples

Figure Psoriatic Arthritis Examples

Figure Ankylosing Spondylitis Examples

Figure Fibromyalgia Examples

Figure United States Musculoskeletal Disorders Therapeutics Sales and Growth Rate (2012-2022)

Figure United States Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2012-2022)

Table United States Musculoskeletal Disorders Therapeutics Sales of Key Manufacturers (2015 and 2016)

Table United States Musculoskeletal Disorders Therapeutics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Musculoskeletal Disorders Therapeutics Sales Share by Manufacturers

Figure 2016 Musculoskeletal Disorders Therapeutics Sales Share by Manufacturers

Table United States Musculoskeletal Disorders Therapeutics Revenue by Manufacturers (2015 and 2016)

Table United States Musculoskeletal Disorders Therapeutics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Musculoskeletal Disorders Therapeutics Revenue Share by Manufacturers

Table 2016 United States Musculoskeletal Disorders Therapeutics Revenue Share by Manufacturers

Table United States Market Musculoskeletal Disorders Therapeutics Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Musculoskeletal Disorders Therapeutics Average Price of Key Manufacturers in 2015

Figure Musculoskeletal Disorders Therapeutics Market Share of Top 3 Manufacturers

Figure Musculoskeletal Disorders Therapeutics Market Share of Top 5 Manufacturers

Table United States Musculoskeletal Disorders Therapeutics Sales by States (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Sales Share by States (2012-2017)

Figure United States Musculoskeletal Disorders Therapeutics Sales Market Share by States in 2015

Table United States Musculoskeletal Disorders Therapeutics Revenue and Market Share by States (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Revenue Share by States (2012-2017)

Figure Revenue Market Share of Musculoskeletal Disorders Therapeutics by States (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Price by States (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Sales by Type (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Sales Share by Type (2012-2017)

Figure United States Musculoskeletal Disorders Therapeutics Sales Market Share by Type in 2015

Table United States Musculoskeletal Disorders Therapeutics Revenue and Market Share by Type (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Musculoskeletal Disorders Therapeutics by Type (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Price by Type (2012-2017)

Figure United States Musculoskeletal Disorders Therapeutics Sales Growth Rate by Type (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Sales by Application (2012-2017)

Table United States Musculoskeletal Disorders Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Musculoskeletal Disorders Therapeutics Sales Market Share by Application in 2015

Table United States Musculoskeletal Disorders Therapeutics Sales Growth Rate by Application (2012-2017)

Figure United States Musculoskeletal Disorders Therapeutics Sales Growth Rate by Application (2012-2017)

Table AbbVie Basic Information List

Table AbbVie Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Figure AbbVie Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Johnson & Johnson Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table Amgen Basic Information List

Table Amgen Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Amgen Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table F. Hoffmann-La Roche Basic Information List

Table F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eli Lilly Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table AstraZeneca Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table Astellas Basic Information List

Table Astellas Musculoskeletal Disorders Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Astellas Musculoskeletal Disorders Therapeutics Sales Market Share (2012-2017)

Table AB Sciences Basic Information List

Table 3SBio Basic Information List

Table Samsung Bioepis Basic Information List

Table Sanofi Basic Information List

Table Taisho Pharmaceutical Basic Information List

Table Takeda Basic Information List

Table Zosano Pharma Basic Information List

Table LG Life Sciences Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Musculoskeletal Disorders Therapeutics

Figure Manufacturing Process Analysis of Musculoskeletal Disorders Therapeutics

Figure Musculoskeletal Disorders Therapeutics Industrial Chain Analysis

Table Raw Materials Sources of Musculoskeletal Disorders Therapeutics Major Manufacturers in 2015

Table Major Buyers of Musculoskeletal Disorders Therapeutics

Table Distributors/Traders List

Figure United States Musculoskeletal Disorders Therapeutics Production and Growth Rate Forecast (2017-2022)

Figure United States Musculoskeletal Disorders Therapeutics Revenue and Growth Rate Forecast (2017-2022)

Table United States Musculoskeletal Disorders Therapeutics Production Forecast by Type (2017-2022)

Table United States Musculoskeletal Disorders Therapeutics Consumption Forecast by Application (2017-2022)

Table United States Musculoskeletal Disorders Therapeutics Sales Forecast by States (2017-2022)

Table United States Musculoskeletal Disorders Therapeutics Sales Share Forecast by States (2017-2022)